Position in TECH
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$14,836,500
+$13,012,893 QoQ
Shares Held
210,000
+540.6% QoQ
Ownership
0.134%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#103
of 588 holders
Holding Since
Sep 2021
10 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in TECH Over Time
Shares Held
Position Value (USD)
Derivatives in TECH
reported options exposure · as of Dec 31, 2024CallValue
$21,609
CallShares
300
PutValue
$345,744
PutShares
4,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CAPSTONE INVESTMENT ADVISORS, LLC holds $45,989,751 across 38 Biotechnology names. TECH ranks #2 (32.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
120,000 | $15,927,600 | |
| 2 | TECH |
BIO-TECHNE Corp
This page
|
210,000 | $14,836,500 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
7,200 | $1,348,416 | |
| 4 | RXRX |
Recursion Pharmaceuticals, Inc.
|
222,378 | $816,127 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,240 | $773,189 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,448 | $719,265 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
12,611 | $692,848 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,899 | $571,655 |
All Filings in TECH
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,836,500 | 210,000 | Shares | Defined | 2026-08-17 | |
| 2025-09-30 | $1,823,607 | 32,781 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $518,255 | 10,073 | Shares | Defined | 2025-08-14 | |
| 2024-12-31 | $21,609 | 300 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $292,153 | 4,056 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $345,744 | 4,800 | Put | Sole | 2025-02-14 | |
| 2024-09-30 | $23,979 | 300 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $231,797 | 2,900 | Put | Sole | 2024-11-14 | |
| 2024-09-30 | $280,234 | 3,506 | Shares | Sole | 2024-11-14 | |
| 2024-03-31 | $14,078 | 200 | Call | Sole | 2024-05-01 | |
| 2024-03-31 | $35,195 | 500 | Put | Sole | 2024-05-01 | |
| 2024-03-31 | $273,605 | 3,887 | Shares | Sole | 2024-05-01 | |
| 2023-09-30 | $217,824 | 3,200 | Put | Sole | 2023-11-13 | |
| 2023-09-30 | $40,842 | 600 | Call | Sole | 2023-11-13 | |
| 2023-09-30 | $580,977 | 8,535 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $187,749 | 2,300 | Put | Sole | 2023-08-10 | |
| 2023-06-30 | $153,382 | 1,879 | Shares | Sole | 2023-08-10 | |
| 2023-06-30 | $48,978 | 600 | Call | Sole | 2023-08-10 | |
| 2022-03-31 | $43,304 | 100 | Put | Sole | 2022-05-13 | |
| 2022-03-31 | $346,432 | 800 | Call | Sole | 2022-05-13 | |
| 2021-09-30 | $242,285 | 500 | Put | Sole | 2021-11-15 | |
| 2021-09-30 | $436,113 | 900 | Call | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||